PMID- 24067406
OWN - NLM
STAT- MEDLINE
DCOM- 20140819
LR  - 20220716
IS  - 1469-4409 (Electronic)
IS  - 0950-2688 (Print)
IS  - 0950-2688 (Linking)
VI  - 142
IP  - 7
DP  - 2014 Jul
TI  - Characterization of hepatitis C infection in tuberculosis patients in an urban 
      city in the USA.
PG  - 1459-66
LID - 10.1017/S0950268813002355 [doi]
AB  - The impact of hepatitis C virus infection (HCI), the most common bloodborne virus 
      infection in the USA, on outcome of active tuberculosis (TB) treatment is largely 
      unknown. We aimed to describe characteristics of TB patients with hepatitis C 
      virus infection (TB-HCI) in King County, Washington, including TB treatment 
      duration and outcome. We reviewed 1510 records of patients treated for active TB 
      at the Public Health - Seattle & King County Tuberculosis Control Program between 
      2000 and 2010, and identified 53 with HCI. Advanced age, being born in the USA, 
      HIV infection, homelessness and injection drug use were independently associated 
      with HCI in TB cases. Independent factors associated with increased treatment 
      duration included HIV infection, excess alcohol use, extrapulmonary TB, and any 
      drug-resistant TB disease. Our findings suggest that TB-HCI patients can be 
      successfully treated for active TB without extending treatment duration.
FAU - Campo, M
AU  - Campo M
AD  - Department of Pulmonary and Critical Care Medicine,University of 
      Washington,WA,USA.
FAU - Shrestha, A
AU  - Shrestha A
AD  - Department of Epidemiology,University of Washington,WA,USA.
FAU - Oren, E
AU  - Oren E
AD  - Department of Epidemiology,University of Washington,WA,USA.
FAU - Thiede, H
AU  - Thiede H
AD  - Department of Epidemiology,University of Washington,WA,USA.
FAU - Duchin, J
AU  - Duchin J
AD  - Department of Epidemiology,University of Washington,WA,USA.
FAU - Narita, M
AU  - Narita M
AD  - Department of Pulmonary and Critical Care Medicine,University of 
      Washington,WA,USA.
FAU - Crothers, K
AU  - Crothers K
AD  - Department of Pulmonary and Critical Care Medicine,University of 
      Washington,WA,USA.
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20130925
PL  - England
TA  - Epidemiol Infect
JT  - Epidemiology and infection
JID - 8703737
RN  - 0 (Antitubercular Agents)
SB  - IM
MH  - Adult
MH  - Antitubercular Agents/adverse effects/therapeutic use
MH  - Coinfection/*epidemiology/microbiology/virology
MH  - Female
MH  - Hepatitis C/*epidemiology/*microbiology
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Treatment Outcome
MH  - Tuberculosis/drug therapy/*epidemiology/*virology
MH  - Washington/epidemiology
PMC - PMC9151201
EDAT- 2013/09/27 06:00
MHDA- 2014/08/20 06:00
PMCR- 2022/05/31
CRDT- 2013/09/27 06:00
PHST- 2013/09/27 06:00 [entrez]
PHST- 2013/09/27 06:00 [pubmed]
PHST- 2014/08/20 06:00 [medline]
PHST- 2022/05/31 00:00 [pmc-release]
AID - S0950268813002355 [pii]
AID - 00235 [pii]
AID - 10.1017/S0950268813002355 [doi]
PST - ppublish
SO  - Epidemiol Infect. 2014 Jul;142(7):1459-66. doi: 10.1017/S0950268813002355. Epub 
      2013 Sep 25.